Heat Biologics Posting Substantial Loss In Afternoon Trading


Shutterstock photo

(RTTNews.com) - Biotechnology company Heat Biologics ( HTBX ) is posting a substantial loss in afternoon trading on Thursday, plunging by 61 percent. Shares of Heat Biologics are pulling back further off the ten-month closing high set on Monday.

The sell-off by Heat Biologics comes following disappointing results from its phase II study of bladder cancer cell vaccine HS-410 in the treatment of non-muscle invasive bladder cancer.

For comments and feedback: contact editorial@rttnews.com




This article appears in: News Headlines
Referenced Symbols: HTBX


More from RTT News

Subscribe






See headlines for HTBX

Follow on: